NATCOPHARM NATCO Pharma Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareNATCOPHARM Chart daily candles · add any indicator · computed in your browser
Loading chart…
Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.
NATCOPHARM Seasonality month by month since 1996 · adjusted month-end closes
NATCOPHARM in October: closed the month higher in 14 of 30 years (1996–2025), with a median move of -0.8% and an average of +1.6%.
Years the month closed higher / years with data, and the median monthly move. Past patterns, not a forecast: most months are close to a coin toss.
Live setups screens NATCOPHARM is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about NATCOPHARM
NATCO Pharma Ltd. did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in NATCO Pharma Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for NATCO Pharma Ltd. is balanced between accumulation and distribution forces.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-19 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
NATCOPHARM — frequently asked questions
What is the NATCO Pharma Ltd. share price today?
NATCOPHARM is trading at ₹800.85 (+2.01% vs previous close), per the latest update on this page.
What is the P/E ratio of NATCO Pharma Ltd.?
NATCOPHARM (NATCO Pharma Ltd.) has a trailing twelve-month P/E ratio of 12.6.
What is the market cap of NATCO Pharma Ltd.?
NATCOPHARM has a market capitalisation of approximately ₹14,736 crore.
Is NATCOPHARM near its 52-week high?
NATCOPHARM is trading -34.7% from its 52-week high of ₹1,226.80 as of 2026-10-19.
What is the RSI of NATCOPHARM?
The 14-day RSI of NATCOPHARM is 43.4, which is considered neutral.
Is NATCOPHARM above its 200-day moving average?
NATCOPHARM is trading below its 200-DMA of ₹935.76 (-14.4% away).
Are FIIs or big investors buying NATCOPHARM?
Strota tracks every bulk and block deal in NATCOPHARM with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.